Caladrius Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CLBS and buy or sell other stocks, options, and ETFs commission-free!

About CLBS

Lisata Therapeutics, Inc. is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. 

CEO
David J. Mazzo, PhD
CEODavid J. Mazzo, PhD
Employees
25
Employees25
Headquarters
Basking Ridge, New Jersey
HeadquartersBasking Ridge, New Jersey
Founded
1980
Founded1980
Employees
25
Employees25

CLBS Key Statistics

Market cap
3.48M
Market cap3.48M
Price-Earnings ratio
-1.10
Price-Earnings ratio-1.10
Dividend yield
—
Dividend yield—
Average volume
10.81K
Average volume10.81K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$4.53
52 Week high$4.53
52 Week low
$1.95
52 Week low$1.95
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.